CytomX Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
CytomX Therapeutics Inc
TickerCTMX
CIK #0001501989
CUSIP23284F105
SectorLife Sciences - Pharmaceutical Preparations
Address343 Oyster Point Blvd Suite 100, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001501989] 10-K
[0001501989] 10-Q
[0001501989] 3
[0001501989] 4
[0001501989] 5
[0001501989] 8-K
[0001501989] D
[0001501989] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
OrbiMed Advisors LLC CytomX Therapeutics Inc [2025-08-14] 0.0
FMR LLC CytomX Therapeutics Inc [2025-08-06] 0.0
Venrock Healthcare Capital Partners III LP CytomX Therapeutics Inc [2025-05-20] 0.0
Longitude Capital Partners V LLC CytomX Therapeutics Inc [2025-05-20] 0.0
Seven Fleet Partners LP CytomX Therapeutics Inc [2025-05-20] 0.0
Point72 Asset Management LP CytomX Therapeutics Inc [2025-05-14] 0.0
Janus Henderson Group PLC CytomX Therapeutics Inc [2024-05-22] 5.3
Cormorant Asset Management LP CytomX Therapeutics Inc [2024-05-13] 7.38
Tang Capital Partners LP CytomX Therapeutics Inc [2022-07-25] 5.3
BlackRock Inc CytomX Therapeutics Inc [2022-07-08] 2.8
Biotechnology Value Fund L P CytomX Therapeutics Inc [2022-01-03] 4.6
RTW Investments LP CytomX Therapeutics Inc [2021-12-08] 8.99
RA Capital Management LP CytomX Therapeutics Inc [2021-01-29] 5.8
Point72 Asset Management LP CytomX Therapeutics Inc [2021-01-26] 0.1
Biotechnology Value Fund L P CytomX Therapeutics Inc [2020-03-06] 3.6
Vanguard Group Inc CytomX Therapeutics Inc [2020-02-11] 5.91
Victory Capital Management Inc CytomX Therapeutics Inc [2020-01-31] 6.19
Price T Rowe Associates Inc /MD/ CytomX Therapeutics Inc [2019-02-14] 9.0
Wellington Management Group LLP CytomX Therapeutics Inc [2019-02-12] 5.95
BlackRock Inc CytomX Therapeutics Inc [2018-02-01] 6.9
Perceptive Advisors LLC CytomX Therapeutics Inc [2017-12-18] 5.6
Biotechnology Value Fund L P CytomX Therapeutics Inc [2017-06-30] 2.6
Canaan IX LP CytomX Therapeutics Inc [2016-02-11] 13.6
Third Rock Ventures LP CytomX Therapeutics Inc [2016-02-10] 24.1
FMR LLC CytomX Therapeutics Inc [2015-11-10] 0.0
Pfizer Inc CytomX Therapeutics Inc [2015-10-21] 9.0
Flynn James E CytomX Therapeutics Inc [2015-10-14] 0.79
Form 3/4/5 Filer 2011 - 2025
Ogden Christopher
CytomX Therapeutics, Inc.
Belvin Marcia
McCarthy Sean A.
Mohindru Mani
Meyers James R
Jones Elaine V
Ashworth Alan
Gilbert Halley E
Su Zhen
Young Matthew P.
Rowland Lloyd A
Chu Yu-Waye
Landau Jeffrey B
Peterson Amy C.
Campoy Carlos
Hannah Alison L
Gluck Frederick W
Scarlett John A
BVF II GP LLC
BVF Partners OS Ltd.
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Lampert Mark N
BVF I GP LLC
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
BVF GP Holdings LLC
Fuchs Charles S.
Knifsend Robin
Kavanaugh William Michael
Humphrey Rachel
Ray Debanjan
Huh Hoyoung
Starr Kevin P
Third Rock Ventures GP, L.P.
TRV GP LLC
Levin Mark J
Third Rock Ventures LP
Tepper Robert I
McCourt Marion
Exter Neil
Goeltz II Robert C.
Canaan IX L.P.
Canaan Partners IX LLC
Ladd Cynthia J
Shannon Timothy M
Deerfield Mgmt L.P.
Flynn James E
Deerfield Mgmt III, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Management Company LP
Deerfield Private Design Fund III, L.P.
Hadley Harbor Master Investors (Cayman) L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
VR Adviser LLC [2025-06-30] SOLE 13,969,882 13,969,882
Tang Capital Management LLC [2025-06-30] OTR 0 11,065,662
Vanguard Group Inc [2025-06-30] SOLE 0 9,311,128
FMR LLC [2025-06-30] DFND 9,238,690 9,238,868
OrbiMed Advisors LLC [2025-06-30] SOLE 8,461,500 8,461,500
Point72 Asset Management LP [2025-06-30] DFND 0 8,084,623
Commodore Capital LP [2025-06-30] SOLE 7,692,300 7,692,300
Perceptive Advisors LLC [2025-06-30] SOLE 6,993,646 6,993,646
Franklin Resources Inc [2025-06-30] DFND 5,769,230 5,769,230
Vivo Capital LLC [2025-06-30] SOLE 5,769,230 5,769,230
Fairmount Funds Management LLC [2025-06-30] SOLE 3,896,582 3,896,582
ProSight Management LP [2025-06-30] SOLE 3,517,113 3,517,113
Baker Bros Advisors LP [2025-06-30] SOLE 3,484,226 3,484,226
RTW Investments LP [2025-06-30] SOLE 3,461,500 3,461,500
Adar1 Capital Management LLC [2025-06-30] SOLE 3,081,414 3,081,414
Balyasny Asset Management LP [2025-06-30] SOLE 2,865,625 2,865,625
RA Capital Management LP [2025-06-30] SOLE 2,661,331 2,661,331
BlackRock, Inc. [2025-06-30] SOLE 2,388,453 2,388,453
Marshall Wace LLP [2025-06-30] OTR 0 2,353,122
Woodline Partners LP [2025-06-30] SOLE 2,336,899 2,336,899
Kynam Capital Management LP [2025-06-30] SOLE 2,154,413 2,154,413
Renaissance Technologies LLC [2025-06-30] SOLE 1,862,200 1,862,200
Geode Capital Management LLC [2025-06-30] DFND 1,745,176 1,745,176
Soleus Capital Management LP [2025-06-30] SOLE 1,304,300 1,304,300
Readystate Asset Management LP [2025-06-30] SOLE 844,643 844,643
Assenagon Asset Management S.A. [2025-06-30] SOLE 720,020 720,020
State Street Corp [2025-06-30] DFND 639,040 639,040
GSA Capital Partners LLP [2025-06-30] SOLE 630,809 630,809
Northern Trust Corp [2025-06-30] DFND 450,107 450,107
UBS Group AG [2025-06-30] DFND 399,035 408,035
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com